 |
chimeric monoclonal antibody against claudin-18 splice variant 2 |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2013-09-26 00:00:00 |
| Sponsor | Astellas Pharma Global Development Inc.;1 Astellas Way;Northbrook, Illinois, 60062 |
